MAP2K4 and epilepsy: Previous preliminary experiment data and other research results showed that miR-27a-3p inhibitors prevented epilepsy-induced inflammatory responses and hippocampal neuronal apoptosis by targeting MAP2K4 (Lu et al., 2019).